Pravastatin lowered coronary disease risk in elderly persons with or at risk for vascular disease

Havranek, Edward
July 2003
ACP Journal Club;Jul/Aug2003, Vol. 139 Issue 1, p9
Academic Journal
Presents an analysis of the effectiveness and safety of pravastatin in coronary disease risk in elderly persons with or at risk for vascular disease. Main outcome measures; Results; Factor which might have lessened the effect of statin therapy on stroke.


Related Articles

  • Older women may need additional screening method for diabetes.  // Geriatrics;Dec98, Vol. 53 Issue 12, p58 

    Presents an abstract of the article `Isolated postchallenge hyperglycemia and the risk of fatal cardiovascular disease in older women and men: The Rancho Bernardo Study,' by E. Barrett-Connor, A. Ferrara which appeared in the August 1998 issue of `Diabetes Care.'

  • Use of Statin Therapy to Reduce Cardiovascular Risk in Older Patients. Wenger, N. K.; Lewis, S. J. // Current Gerontology & Geratrics Research;2010, p1 

    Background. Cardiovascular disease is the principal cause of mortality in older individuals, and more than 80% of deaths due to coronary heart disease or stroke occur in patients over 65 years of age. Hyperlipidemia is one of the main modifiable risk factors for cardiovascular disease. Current...

  • Statins bring long-term falls in non-CVD disease. Anekwe, Lilian // Pulse;9/7/2011, Vol. 71 Issue 28, p15 

    The article reports on the result of a study conducted by researchers in Great Britain, which shows that long-term intake of statins decreases the risk of non-fatal myocardial infarction and fatal coronary heart disease (CHD).

  • Metabolic factors linked to ischemic heart disease.  // Geriatrics;May2001, Vol. 56 Issue 5, p61 

    Presents an abstract of the study `Metabolic Syndrome and Ischemic Heart Disease in Elderly Men and Women,' by U. Lindblad, R.D. Langer et al., from the March 2001 issue of `American Journal of Epidemiology.'

  • Researchers Pinning Down Risk of Heart Disease, Stroke.  // FDA Consumer;May/Jun99, Vol. 33 Issue 3, p5 

    Deals with age as a risk factor in developing coronary heart disease (CHD) in the lifetime of men and women. Age where the risk of CHD is high; People in the United States affected by CHD; Signs and symptoms; Role of ultrasound test in predicting heart attack or stroke risk.

  • Homocysteine, B[sub 12], and folate levels are all associated with CAD risk in the elderly.  // Modern Medicine;Feb98, Vol. 66 Issue 2, p36 

    Discusses the abstract `Association Between Plasma Homocysteine and Coronary Artery Disease in Older Persons,' by W.S. Aronow and C. Ahn, which appeared in the November 1, 1997 issue of `American Journal of Cardiology.'

  • Improving Mortality Prediction Using Biosocial Surveys. Noreen Goldman; Dana A. Glei; Yu-Hsuan Lin; Maxine Weinstein // American Journal of Epidemiology;Mar2009, Vol. 169 Issue 6, p769 

    The authors used data from a nationally representative survey of 933 adults aged 54 years or older (mean age = 66.2 years; standard deviation, 8.0) in Taiwan to explore whether mortality prediction at older ages is improved by the use of 3 clusters of biomarkers: 1) standard...

  • Association of serial measurements of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults. Parham, Kelly // Annals of Clinical Biochemistry;May2011, Vol. 48 Issue 3, p293 

    The article focuses on the association of cardiac troponin T serial measurements in the incident rate risk of heart failure (HF) and cardiovascular death. It states that earlier study use models which uses troponin measurements but fails to detect troponin in the major population. It mentions...

  • Evaluation of Lipid-Lowering Therapy and Cholesterol Goal Attainment in Finland: The National FINRISK Study. Alemao, Evo; Yin, Don; Sintonen, Harri; Salomaa, Veikko; Jousilahti, Pekka // American Journal of Cardiovascular Drugs;2006, Vol. 6 Issue 5, p349 

    BACKGROUND: European and US study findings show that patients in primary care and specialty care are not adequately treated for cholesterol reduction. OBJECTIVE: To evaluate lipid-lowering treatment in Finland, estimate the proportions of subjects who are achieving cholesterol goals, and assess...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics